top of page

Posters

ESMO 2024 V2.jpg

Circulating hPG80 (WNT pathway activation) as a potential new prognostic/ predictive factor of immunotherapy (ICI) efficacy: ONCOPRO prospective study

You, B | 2024 ESMO Annual Meeting
ASCO 2023.jpg

Diagnostic value of hPG80, as a new multi-cancer blood biomarker, in 16 different cancers: Results of the ONCOPRO prospective study

You, B | 2023 ASCO Annual Meeting
ASCO 2021.jpg

Plasma hPG80 (circulating Progastrin) levels in cancer patients in Nigeria: Prolevcan study

Fatiregun, O | 2021 ASCO Annual Meeting
ASCO 2021.jpg

Prognostic value of plasma hPG80, alone or in combination with AFP in patients with hepatocellular carcinoma

Assenat, E | 2021 ASCO Annual Meeting

hPG80 (Progastrin), a novel blood-based biomarker for detection of neuroendocrine neoplasms.

largebanner.jpg

#GI ASCO 2020

Chauhan, A | 2020 ASCO Gastrointestinal Cancers Symposium
bottom of page